- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03004027
Enhancing Psychological Self-help With Implementation Intentions
Enhancing Psychological Self-help With Implementation Intentions for Those With Visible Skin Difference and Fear of Negative Evaluation
Individuals with visible conditions often report experiencing lowered social confidence and encountering intrusive reactions from others, yet relatively few targeted psychosocial self help interventions are available.
The investigators will conduct a randomised controlled trial to compare the efficacy of an adapted form of an existing self-help intervention with an enhanced version of the same intervention that incorporates if-then planning instructions (or 'implementation intentions') and a control condition that will receive support as usual. Participants who self-identify as having a visible condition affecting the skin or hair, or scarring to the skin that negatively affects their social confidence will be allocated to one of three conditions: augmented self-help, standard self help or control. The interventions will be delivered online and participants will complete psychometric outcome measures at two time points, four weeks apart.
It is hypothesised that participants who receive the augmented self help intervention will have a statistically significant decrease in fear of negative evaluation in comparison to both the standard self-help and support as usual control groups.
Study Overview
Detailed Description
The proposed research will take the form of a randomised controlled trial conducted in accordance with CONSORT guidelines (http://www.consort-statement.org). Data will be collected online using Qualtrics. Participants will be required to answer all fields on Qualtrics, as a way of managing potential missing data.
Participants will be randomly allocated to one of three groups: (i) psychological self-help augmented with implementation intentions, (ii) standard psychological self-help or (iii) a no intervention waiting list control. Qualtrics will be used to randomly allocate participants to one of the three groups.
A sample size analysis has been conducted and calculated assuming two measures, three groups, an alpha of 0.05, a power of 0.8, and an effect size of 0.25; a total sample size of 120 participants would be needed (i.e. 40 per group). Allowing for an attrition rate of 20%, 144 participants would need to be recruited (i.e. 48 per group). Although participants will be randomised to condition, it is best practice for any differences at baseline to be controlled for in analyses and thus a between factors repeated measure analysis of variance (ANOVA) will be conducted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Yorkshire
-
Sheffield, South Yorkshire, United Kingdom, S1 2LT
- University of Sheffield
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants self-identify as having a visible skin difference
- Participants will be aged 18 years or over
- Participants will be fluent in the English language
Exclusion Criteria:
Participants will be excluded if they are currently receiving psychotherapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Enhanced
self help leaflet enhanced with implementation intentions
|
Self help leaflet entitled 'Building confidence in social situations: A guide for people living with a visible skin differences'
|
|
Active Comparator: Standard
self help leaflet standard (without implementation intentions)
|
Self help leaflet entitled 'Building confidence in social situations: A guide for people living with a visible skin differences'
|
|
No Intervention: Waiting list control
Baseline measures administered only.
self help intervention will be made available once the study has finished.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Brief Fear of Negative Evaluation-II at four weeks (Carleton, Collimore, & Asmundson, 2007)
Time Frame: At baseline and four weeks
|
At baseline and four weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Generalised Anxiety Disorder 7 at four weeks
Time Frame: At baseline and four weeks
|
At baseline and four weeks
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Patient Health Questionnaire 9 at four weeks
Time Frame: At baseline and four weeks
|
At baseline and four weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jessica C Lane, University of Sheffield
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 147400
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Social Anxiety
-
Aya Technologies LimitedCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)United Kingdom
-
Tel Aviv UniversityCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)Israel
-
University of ManchesterManchester University NHS Foundation TrustCompletedSocial Anxiety | Social Anxiety Disorder | Social PhobiaUnited Kingdom
-
Aya Technologies LimitedCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)United Kingdom
-
Hong Kong Shue Yan UniversityNot yet recruitingSocial Phobia | Social Anxiety Disorder (SAD)
-
University of BernUniversity of LuebeckCompletedSocial Anxiety Disorder (Social Phobia)Switzerland
-
University of BernCompletedSocial Anxiety | Social Anxiety DisorderSwitzerland
-
University of Wisconsin, MilwaukeeTerminatedSocial Anxiety | Social Anxiety DisorderUnited States
-
Weill Medical College of Cornell UniversityBrain & Behavior Research FoundationTerminatedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder of ChildhoodUnited States
-
Stockholm UniversityPBM; MimerseCompletedSocial Anxiety | Public Speaking | Social Anxiety Disorder, Performance OnlySweden
Clinical Trials on Self help leaflet
-
The University of Hong KongNot yet recruiting
-
Francine RosselliWesleyan UniversityUnknownObesity | Binge Eating DisorderUnited States
-
Memorial University of NewfoundlandCompletedBinge Eating DisorderCanada
-
Chinese University of Hong KongNot yet recruitingDepression | Insomnia
-
National Institute of Diabetes and Digestive and...Completed
-
Beijing Normal UniversityNot yet recruitingSmoking Cessation | Mobile HealthChina
-
University of NottinghamUnknownCarer Stress SyndromeUnited Kingdom
-
Beijing Normal UniversityRecruiting
-
Oxford Health NHS Foundation TrustCompletedBulimia Nervosa | Binge Eating Disorder | Eating Disorder Not Otherwise SpecifiedUnited Kingdom